
|Articles|November 1, 2004
Hylaform Plus wins FDA nod for wrinkle correction
National report - The U.S. Food and Drug Administration (FDA) has approved Hylaform Plus (Hylan-B gel), a large-particle-size hyaluronic acid-based dermal filler indicated for the correction of moderate to severe facial wrinkles and folds.
Advertisement
Newsletter
Like what you’re reading? Subscribe to Dermatology Times for weekly updates on therapies, innovations, and real-world practice tips.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Dermatology Times
1
Medicus Pharma Completes Phase 2 Enrollment of D-MNA Study to Non-Invasively Treat BCC
2
First-in-Class Topical GT20029 Demonstrates Promising Phase 2 Efficacy and Tolerability for AGA
3
Phase 2 Nemolizumab Trial Opens for CPUO
4
Global Hidradenitis Suppurativa Atlas (GHiSA) Finds HS Affects 1% of the World's Population
5


















